bibliographicCitation |
Chou J, Su H, Chen L, Liao Y, Hartman-Frey C, Lai Y, Yang H, Deatherage DE, Kuo C, Huang Y, Yan PS, Hsiao S, Tai C, Lin HL, Davuluri RV, Chao T, Nephew KP, Huang TH, Lai H, Chan MW. Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer. Laboratory Investigation. 2010 Jan 11;90(3):414–25. doi: 10.1038/labinvest.2009.138. |